Solid Biosciences advances gene therapy trials across muscle diseases

Go back to Solid Biosciences advances gene therapy trials across muscle diseases
(NASDAQ: SLDB) Delayed: 8.70 -0.37 (4.08%)
Previous Close $9.07    52 Week High
Open $9.20    52 Week Low
Day High $9.37    P/E N/A 
Day Low $8.66    EPS
Volume 1,113,838